National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
1,600 enrolled
CEMI-LUNG
Recruiting
500 enrolled
Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes
Recruiting
300 enrolled
Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces
Recruiting
500 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Recruiting
105 enrolled
LUCID
Recruiting
100 enrolled
Clinical Outcomes and Quality Of Life After Minimally Invasive Segmentectomy Versus Lobectomy for Lung Cancer.
Recruiting
180 enrolled
MK-3475-U01
Recruiting
1,065 enrolled
ORI-EGI-03
Recruiting
450 enrolled
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Recruiting
538 enrolled
Experiences w/ & Attitudes Towards Immune Chckpt Inhibitors in NSCLC Patients Single Center Survey Based Study
Recruiting
40 enrolled
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Recruiting
1,000 enrolled
LEPIDOPTERA
Recruiting
380 enrolled
PRO-ACTIVE
Recruiting
850 enrolled
ELEPHAS-04
Recruiting
324 enrolled
Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
Recruiting
1,000 enrolled
Evaluation for NCI Surgery Branch Clinical Research Protocols
Recruiting
7,000 enrolled
Rapid Autopsy and Procurement of Cancer Tissue
Recruiting
275 enrolled
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Recruiting
500 enrolled
A Hierarchical Multi-modal AI Framework for Pathological and Genetic Subtyping of Lung Cancer Based on PET/CT Imaging
Recruiting
5,500 enrolled
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Recruiting
500 enrolled
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
1,100 enrolled
COPD Care Pathway Among Patients With Cancer
Recruiting
101 enrolled
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Recruiting
800 enrolled
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
Recruiting
208 enrolled
MOMENTUM
Recruiting
8,000 enrolled
The Rise in Robotic Atypical Segmentectomies
Recruiting
600 enrolled
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
Recruiting
100 enrolled
CureLung
Recruiting
500 enrolled
OSIREAL
Recruiting
500 enrolled
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
Recruiting
130 enrolled
To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)
Recruiting
100 enrolled
LUNG-ROLL
Recruiting
60,000 enrolled
SPARROW
Recruiting
190 enrolled
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
Recruiting
40 enrolled
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Recruiting
700 enrolled
Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
Recruiting
900 enrolled
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
Recruiting
800 enrolled
A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC
Recruiting
500 enrolled
DP-04
Recruiting
100 enrolled
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Recruiting
750 enrolled
RACE-2L
Recruiting
250 enrolled
DeniLA
Recruiting
200 enrolled
Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy
Recruiting
100 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
A Registry for People With Lung Cancer
Recruiting
600 enrolled
Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer
Recruiting
150 enrolled
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
Recruiting
500 enrolled
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Recruiting
1,310 enrolled
Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit
Recruiting
236 enrolled